Purchase Order W81K0020P0348
Award Date
10/1/20
Potential Completion Date
9/30/25
Potential Value
$4.6M
Federal Agency
Medical Command
Awardee
Biofire Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Biofire Diagnostics LLC, a biotech company specializing in infectious disease testing. The contract, valued at $123,101.50, is for the provision of a GI PANEL PN RFIT-ASY-0116 product. No set-aside designation was used. Biofire Diagnostics LLC is an experienced federal contractor, holding multiple indefinite delivery contracts and blanket purchase agreements with various agencies, including...
The Department of the Army Medical Command awarded a $232,200 firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the supply of respiratory panels and blood culture ID panels for a FilmArray analyzer. The purchase order was awarded on October 1, 2018 with a completion date of September 30, 2019. This procurement was not set aside for any small business program. The original solicitation was a sources sought notice for Tripler Army Medical...
This firm-fixed-price purchase order was awarded to Biofire Diagnostics LLC by the Defense Health Agency to provide FDA-approved molecular diagnostic panels compatible with the BioFire Torch system. The $1,881,825.06 contract covers a base period through September 30, 2025 and includes respiratory, blood culture identification, and meningitis panels with specific pathogen targets. This requirement originated from a sources sought notice for Tripler Army Medical Center. The award does not have...
This federal contract award, valued at $87,256.85, was issued by the U.S. Army Medical Command (MEDCOM) to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The award is for the supply of medical equipment, specifically "ME PANEL IVD", under a Firm Fixed Price purchase order contract. Biofire Diagnostics LLC holds a General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests,...
This is a $24,117.80 firm fixed price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract is for the supply of a GI Panel In-Vitro Diagnostic (IVD) testing kit. No set-aside designation was used. Biofire Diagnostics LLC holds several indefinite delivery and blanket purchase agreements with federal customers such as the Department of Veterans Affairs (VA) Veterans Health...
This is a firm-fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the supply of reagents for the Biofire FilmArray system. The award has a ceiling value of $911,174.06 and a completion date of September 30, 2018. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to federal agencies, including the Department of Veterans Affairs, Defense...
This is a Firm Fixed Price delivery order awarded by the Bureau of Medicine and Surgery (part of the Department of Defense) to Biofire Diagnostics LLC, a for-profit biotech company, for a respiratory panel test kit. The order is under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The $91,954.46 award has a period of performance through June 30, 2018. Biofire Diagnostics previously received other federal...
This federal contract award was issued by the Department of Defense's Medical Command (MEDCOM) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $1,360,249.83 firm-fixed-price delivery order was placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract for in-vitro diagnostics, reagents, and tests. The contract is for the supply of a GI PANEL, RFIT-ASY-0116 product, with a completion date...
This contract was awarded by the Defense Health Agency to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The $480,000.00 firm fixed price contract provides reagents and instruments such as a pneumonia verification kit, respiratory panel, and blood culture identification panel. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro...
This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to BioFire Diagnostics LLC, a foreign-owned for-profit organization, for $322,645.64. The contract is for the provision of FDA-approved respiratory, blood culture identification, and meningitis/encephalitis diagnostic panels using BioFire's FilmArray Torch multiplex PCR instrument. This award has a 12-month base period from March 25, 2020 to September 30, 2020, with two 12-month option...